Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects

The anti-tumour effects of thalidomide have been associated with its anti-angiogenic properties. Second generation thalidomide analogues are distinct compounds with enhanced therapeutic potential. Although these compounds are beginning to enter trials for the treatment of cancer there is very little...

Descripción completa

Detalles Bibliográficos
Autores principales: Dredge, K, Marriott, J B, Macdonald, C D, Man, H-W, Chen, R, Muller, G W, Stirling, D, Dalgleish, A G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376196/
https://www.ncbi.nlm.nih.gov/pubmed/12402158
http://dx.doi.org/10.1038/sj.bjc.6600607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376196/
https://www.ncbi.nlm.nih.gov/pubmed/12402158
http://dx.doi.org/10.1038/sj.bjc.6600607

Ejemplares similares